new glp 1 drug Eli Lilly to seek approval of GLP-1 weight-loss this year GLP-1 Drugs: 6 Things We've

We will guide you through the process, monitor your results, and adjust your treatment as needed to achieve the best results

Unlike experimental peptides, FDA-approved medications undergo years of human trials and are subject to regulated manufacturing and distribution

With OptiMantra, clinics can: Build customizable peptide therapy templates tailored to wellness, performance, and aesthetic programs Link peptide prescriptions directly to labs, progress notes, and individualized treatment plans Track outcomes over time to optimize protocols and improve patient results Maintain clean, audit-ready documentation that supports compliance and operational efficiency As the most in-demand peptides of 2026 reshape patient expectations, clinics equipped with structured, data-driven systems are best positioned to grow

3 As of May 30, 2025